This manual gives guidance for the x-ray reading in TB Suspects and provides a useful tool for better diagnosing of smear-negative TB in adult TB suspects.
This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
This webpage provides summary information on Connecticut's quarantine laws.
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers. This guide is designed to be used in combination with the WHO TB Prevalence Surveys: A Handbook.
The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing.
This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).
This fact sheet describes Mycobacterium bovis (bovine tuberculosis) in humans. It is also available in English.
This fact sheet provides information on the Xpert MTB/RIF Assay.
This poster raises awareness about TB and encourages people to seek medical attention by calling a local number if they experience TB symptoms. It was developed for and tested with low-literacy Spanish-speaking populations to optimize linguistic and cultural appropriateness.
The poster is available in three sizes: 8"x10", 11"x17", and 24"x36".
